
Sign up to save your podcasts
Or
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
4.5
88 ratings
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
17 Listeners
2,431 Listeners
112,376 Listeners
675 Listeners
56,444 Listeners
612 Listeners
5 Listeners
11 Listeners
52 Listeners
10 Listeners
18 Listeners
1 Listeners
0 Listeners
292 Listeners